Evidence map›Paper›PMID 27558171›Full record

ArticleSystematic reviews2016

Smokeless tobacco and oral potentially malignant disorders in South Asia: a protocol for a systematic review.

Zohaib Khan, Sheraz Khan, Lara Christianson, Sara Rehman, Obinna Ekwunife, Florence Samkange-Zeeb

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Zohaib KhanLeibniz Institute for Prevention Research and Epidemiology-(BIPS), Achterstrasse 30, 28359, Bremen, Germany. khan@bips.uni-bremen.de.ORCID 0000-0002-1885-8254
Sheraz KhanPakistan Cancer Support Group, Khyber Pakhtunkhwa, Pakistan.
Lara ChristiansonLeibniz Institute for Prevention Research and Epidemiology-(BIPS), Achterstrasse 30, 28359, Bremen, Germany.
Sara RehmanKhyber Medical University, Peshawar, Pakistan.
Obinna EkwunifeLeibniz Institute for Prevention Research and Epidemiology-(BIPS), Achterstrasse 30, 28359, Bremen, Germany.
Florence Samkange-ZeebLeibniz Institute for Prevention Research and Epidemiology-(BIPS), Achterstrasse 30, 28359, Bremen, Germany.
Hochschule Bremen · DEKhyber Medical University · PKGovernment of Khyber Pakhtunkhwa · PKLeibniz Institute for Prevention Research and Epidemiology - BIPS · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOral potentially malignant disorders (OPMDs) are chronic lesions or conditions characterized by a potential for malignant transformation. Apart from being possible pre-cursors to oral cancer, OPMDs themselves are usually painful and debilitating conditions having an influence on the quality of life, both in terms of pain and social disability. Smokeless tobacco (SLT) use is considered a major risk factor for OPMDs. SLT use is a culturally and socially acceptable habit in South Asia. According to a recent report, 90 % of the SLT burden of the whole world lies in the South Asian countries of Pakistan, India, Sri Lanka, Bangladesh, Bhutan, Nepal, Afghanistan, and Maldives. This review aims to assess the association between the use of various SLT products in South Asia and risk of OPMDs.

methodsThis review will focus on epidemiological studies on the use of SLT and risk modification for OPMDs, which have been carried out in the human population of South Asian countries. Articles reporting estimates of relative risk, e.g., odds ratio (OR) or relative risk (RR) with their 95 % confidence intervals (CI) for SLT users versus non-users. Articles reporting data from which these effect estimates can be computed will be included in the review. We will search MEDLINE, the Science Citation Index (SCI), Scopus, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases for relevant literature using a combination of keywords and MeSH terms, where applicable. Appropriate sources of gray literature will also be included in the search. The electronic searches will be supplemented by a hand search of the bibliographies of the included articles. The included studies will be assessed for their quality using an established quality assessment tool. All relevant data from the included articles will be recorded in an MS Excel spread sheet and then transferred to Rev Man 5.3 to carry out a meta-analysis. Heterogeneity among the estimates will be assessed through the I (2) statistic. Sensitivity and subgroup analysis will be carried out to see the effects of individual or group of studies on the pooled effect estimate. Results of the review will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. DISCUSSION: This review may have a potential limitation with regard to the designs of the studies included as we expect that most of the included studies will be of the observational types. We will however try to address this issue by conducting sensitivity and subgroup analysis of similar quality studies. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42015029705 .

Indexed as

AsiaHealth Knowledge, Attitudes, PracticeHumansMouth NeoplasmsPrecancerous ConditionsQuality of LifeRisk FactorsSystematic Reviews as TopicTobacco, SmokelessTobacco UseBetel quidErythroplakiaGutkhaLeukoplakiaOral potentially malignant disordersPaanSmokeless tobaccoSouth AsiaSubmucous fibrosis

Identifiers

PMID27558171
PMCPMC4997723
OpenAlexW2515488818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.